To include your compound in the COVID-19 Resource Center, submit it here.

Confluent: Low tech isn't no tech

The mainstays of traditional cancer therapy have been surgical excision, chemotherapy, and radiation therapy. Cutting edge developments in research and trials involve the development of specific or autologous cancer vaccines, anti-angiogenic factors to prevent vascularization and growth, and

Read the full 381 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers